U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight:
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
About
Search Substances
INFLUENZA B VIRUS B/WISCONSIN/1/2010 RECOMBINANT HEMAGGLUTININ ANTIGEN
N9C76986U2
Possibly Marketed Outside US
Source:
BLA125285
(2013)
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8aa934c-d74e-4c7c-b2fc-d3b8b46f4529
First approved in 2013
Source:
BLA125285
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8aa934c-d74e-4c7c-b2fc-d3b8b46f4529
General
Names
1
Related Substances
1
INFLUENZA B VIRUS B/WISCONSIN/1/2010 RECOMBINANT HEMAGGLUTININ ANTIGEN
N9C76986U2
Possibly Marketed Outside US
Source:
BLA125285
(2013)
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8aa934c-d74e-4c7c-b2fc-d3b8b46f4529
First approved in 2013
Source:
BLA125285
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8aa934c-d74e-4c7c-b2fc-d3b8b46f4529
Approval Year
2013
80
Name
Type
Language
INFLUENZA B VIRUS B/WISCONSIN/1/2010 RECOMBINANT HEMAGGLUTININ ANTIGEN
Source:
Common Name
English
ACTIVE MOIETY
N9C76986U2
INFLUENZA B VIRUS B/WISCONSIN/1/2010 RECOMBINANT HEMAGGLUTININ ANTIGEN
